Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024

Since the end of November 2023, the European Mortality Monitoring Network (EuroMOMO) has observed excess mortality in Europe. During weeks 48 2023-6 2024, preliminary results show a substantially increased rate of 95.3 (95% CI:  91.7-98.9) excess all-cause deaths per 100,000 person-years for all age...

Descripción completa

Detalles Bibliográficos
Autores: Nørgaard, Sarah K, Nielsen, Jens, Nordholm, Anne Christine, Richter, Lukas, Chalupka, Alena, Sierra, Natalia Bustos, Braeye, Toon, Athanasiadou, Maria, Lytras, Theodore, Denissov, Gleb, Luomala, Oskari, Fouillet, Anne, Pontais, Isabelle, An der Heiden, Matthias, Zacher, Benedikt, Weigel, Alina, Foppa, Ivo, Gkolfinopoulou, Kassiani, Panagoulias, Ioannis, Paldy, Anna, Malnasi, Tibor, Domegan, Lisa, Kelly, Eva, Rotem, Naama, Rakhlin, Oksana, de'Donato, Francesca K, Di Blasi, Chiara, Hoffmann, Patrick, Velez, Telma, England, Kathleen, Calleja, Neville, van Asten, Liselotte, Jongenotter, Femke, Rodrigues, Ana Paula, Silva, Susana, Klepac, Petra, Gomez-Barroso, Diana, Leon-Gomez, Inmaculada, Galanis, Ilias, Farah, Ahmed, Weitkunat, Rolf, Fehst, Katarina, Andrews, Nick, Clare, Tom, Bradley, Declan T, O'Doherty, Mark G, William, Naoma, Hamilton, Mark, Søborg, Bolette, Krause, Tyra G, Bundle, Nick, Vestergaard, Lasse S
Tipo de recurso: artículo
Fecha de publicación:2024
País:España
Institución:Instituto de Salud Carlos III (ISCIII)
Repositorio:Repisalud
Idioma:inglés
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/19373
Acceso en línea:http://hdl.handle.net/20.500.12105/19373
Access Level:acceso abierto
Palabra clave:Influenza, Human
COVID-19
Respiratory Syncytial Virus, Human
Respiratory Syncytial Virus Infections
Adult
Humans
Europe
Seasons
Descripción
Sumario:Since the end of November 2023, the European Mortality Monitoring Network (EuroMOMO) has observed excess mortality in Europe. During weeks 48 2023-6 2024, preliminary results show a substantially increased rate of 95.3 (95% CI:  91.7-98.9) excess all-cause deaths per 100,000 person-years for all ages. This excess mortality is seen in adults aged 45 years and older, and coincides with widespread presence of COVID-19, influenza and respiratory syncytial virus (RSV) observed in many European countries during the 2023/24 winter season.

Similares en LA Referencia